Drugs / L-756423
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00002424 | — | HIV infectious disease | Merck Sharp & Dohme LLC | Suspended | No outcome recorded |
| Phase 2 | NCT00002452 | — | HIV infectious disease | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-756423 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002452 ↗ |
| Modality | Small molecule | — CHEMBL1233940 ↗ |